Log in to save to my catalogue

Prognostic factors and outcomes of adjuvant and first-line metastatic treatments in melanoma a Turki...

Prognostic factors and outcomes of adjuvant and first-line metastatic treatments in melanoma a Turki...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_9828f0522bfd4c938176e3ac69348cb2

Prognostic factors and outcomes of adjuvant and first-line metastatic treatments in melanoma a Turkish oncology group study

Publication information

Publisher

London: Nature Publishing Group UK

More information

Scope and Contents

Contents

Management of melanoma has changed significantly with the discovery of targeted therapies and immune checkpoint inhibitors (ICI). Our aim in the study is to determine which treatment alternatives, specifically dabrafenib plus trametinib and ICIs, are effective in adjuvant therapy and which treatment is effective as first-line metastatic therapy. Th...

Alternative Titles

Full title

Prognostic factors and outcomes of adjuvant and first-line metastatic treatments in melanoma a Turkish oncology group study

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_9828f0522bfd4c938176e3ac69348cb2

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_9828f0522bfd4c938176e3ac69348cb2

Other Identifiers

ISSN

2045-2322

E-ISSN

2045-2322

DOI

10.1038/s41598-025-87553-z

How to access this item